Whereas the biologics treatment have been one of the most advanced solution to slow down the disease, they were not yet directly made for only treating Ankylosing Spondylitis.
Today they are looking for drug that is more addressed for this condition.
A recent release is Secukinumab, trade name Cosentyx, which treats psoriasis, ankylosing spondylitis, and psoriatic arthritis.